ŞBŞebnem Bıçakcı

Şebnem Bıçakcı

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Şebnem Bıçakcı has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The clinical profile and therapeutic outcome of patients diagnosed with “atypical” optic neuritis

    by Gülden Akdal, Hülya Ertaşoğlu Toydemir, Meltem Söylev Bajin, Pınar Özçelik, Figen Gökçay, Ayşe İlksen Işıkay, Canan Togay Işıkay, Şebnem Bıçakçı, Aylin Yaman, Pembe Keskinoğlu, et al.

    Purpose Our aim was to evaluate the clinical characteristics and prognosis of patients diagnosed with atypical optic neuritis (AON). Methods We performed a retrospective study in patients with AON collected between 1991 and 2024. Clinical features, laboratory findings, and treatment modalities of patients with AON were investigated and the relationship between therapeutic approaches and the visual prognosis of these patients were evaluated. Results Eighty-eight patients with AON were evaluated and 51 patients were included in the study. Patients were divided in two groups (Group 1: full recovery, Group 2: partial and no recovery). Anti-MOG antibodies were positive in 8 patients. Seven patients out of 8 had full recovery whereas 1 patient had partial recovery. Among 7 patients with AQP4-Ab positivity, 4 patients had no recovery, 1 patient had partial recovery and 2 patients had full recovery. MOG-Ab positivity and intravenous methylprednisolone (IVMP) treatment in patients with full recovery were found to be significantly higher than in patients with partial recovery and no recovery (p = 0.011 and p = 0.010 respectively). Patients who were treated with plasma exchange (PE), intravenous immunoglobulin (IVIg) and immunsupressive agents had longer recovery time according to Kaplan -Meier survival curves (p = 0.023, p = 0.039 and p = 0.032). Conclusion MOG-Ab positivity and IVMP treatment are related with better visual outcome. Early diagnosis and treatment of AON are extremely important to rescue vision. Treatment in patients with AON should be started as soon as possible, even if the serological status is not known at the setting of ON.


  • Comparison of clinical features in patients with vestibular migraine and migraine

    by Neşe Çelebisoy, Ayşın Kısabay Ak, Ceyla Ataç, Hüseyin Nezih Özdemir, Figen Gökçay, Gülsüm Saruhan Durmaz, Dilek Top Kartı, Hülya Ertaşoğlu Toydemir, Vildan Yayla, İlKsen Çolpak Işıkay, et al.

    Vestibular migraine (VM) is accepted as the most common cause of spontaneous episodic vertigo. In most patients, vestibular symptoms follow migraine headaches that begin earlier in life. The aim of this multicenter retrospective study was to find out the differences between migraine patients without any vestibular symptoms (MwoV) and VM patients and to delineate the specific clinical features associated with VM. MwoV and VM patients were compared regarding demographic features, migraine headache years, headache attack frequency, intensity, symptoms associated with headache and vertigo attacks, presence of menopause, history of motion sickness and family history of migraine. Four-hundred and forty patients with MwoV and 408 patients with VM were included in the study. Migraine with aura was more frequent in patients with MwoV (p = 0.035). Migraine headache years was longer (p < 0.001) and headache intensity was higher in patients with VM (p = 0.020). Aural fullness/tinnitus was more common in patients with VM (p < 0.001) when all other associated symptoms were more frequent in patients with MwoV (p < 0.001) as well as attack triggers (p < 0.05). Presence of menopause and motion sickness history was reported more frequently by VM patients (p < 0.001). Logistic regression analysis indicated that longstanding history of migraine with severe headache attacks, aural fullness/tinnitus accompanying attacks, presence of menopause, previous motion sickness history were the differentiating clinical features of patients with VM.


  • Vestibular migraine, demographic and clinical features of 415 patients: A multicenter study

    by Neşe Çelebisoy, Ayşın Kısabay Ak, Hüseyin Nezih Özdemir, Figen Gökçay, Gülsüm Saruhan Durmaz, Dilek Top Kartı, Hülya Ertaşoğlu Toydemir, Vildan Yayla, Ayşe İlksen Çolpak Işıkay, İrEm Erkent, et al.


  • Open Access

    Migren ve Hastalık Birlikteliği

    by Şebnem Biçakçi

    Migraine is a common neurological disorder and can be severely disabling during attacks. The highest prevalence occurs between the ages of 25 and 55 years. Prior studies have found that migraine occurs together with other illnesses at a greater coincidental rate than is seen in the general population. These occurrences are called “comorbidities”. To delineate the comorbidities of migraine is important, because it can help improve treatment strategies and the understanding of the possible pathophysiology of migraine.